40 years of service
Oculus director Rainer Kirchhübel celebrates 40th work anniversary


Colin Kerr
Published: Friday, March 1, 2019
[caption id="attachment_14278" align="alignleft" width="886"]
Rainer Kirchhübel (left) receiving a certificate in honour of his 40th work anniversary from Andreas Tielmann, Managing Director of the Chamber of Industry and Commerce in Lahn-Dill[/caption]
“You have dedicated your entire working life to OCULUS,” said Co-Director Christian Kirchhübel, at a special ceremony to mark his father’s Rainer Kirchhübel 40th work anniversary.
Rainer Kirchhübel said: “For 38 of my 40 years at OCULUS, I’ve been the Director. These years saw many great challenges, but I always enjoyed it.”
A spokeswoman for Oculus said that from his start at the firm in 1979, engineer Rainer Kirchhübel led the company success as a worldwide high-tech company, and she also pointed out that OCULUS is still a family company. Sons Christian and Matthias are executives at the company, and Rainer’s wife Rita Kirchhübel has been Director of Marketing for over 25 years.
www.oculus.de

Tags: OCULUS
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.